None listed
Conditions
Interventions
Intervention1: Group C: Vaginal Misoprostol before MVA: Group C: 400 mcg Misoprostol 3 hours before MVA
Intervention2: Group D: Vaginal Misoprostol before VA: Group D: 400 mcg Misoprostol 3 hours
Sponsors
Ministry of health & family Welfare,Delhi
Eligibility
Inclusion criteria
Inclusion criteria: INCLUSION CRITERIA ? Women seeking medical termination of pregnancy ? Gestational age <10 completed wks of pregnancy ? Willing to participate in the study, give and sign a consent form ? Has a normal single intrauterine pregnancy less than 10 completed weeks on the day of vacuum aspiration/MVA ? Agrees to return for a scheduled follow up visit 7-14 days after the surgery.
Exclusion criteria
Exclusion criteria: EXCLUSION CRITERIA ? For the study previous caeserean ? Allergy to misoprostol ? History of or evidence of disorders C/I to use of PGs - Mitral stenosis - Glaucoma - sickle cell anaemia - diastolic BP>90 mms Hg - Bronchial asthma - systolic BP<90 mm Hg - anemia (Hb<100 g/l) or any coagulation disorder. - Chronic medical disorder that requires special care or treatment or precautions - C/ I steroid - anticoagulant therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome:complete abortion.The composite variable of all complications combined is the other main outcome variable of the study.Timepoint: 7-14 Days after VA/MVA | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of subjects will specific complications, cervical tear with or without suture, suspected or confirmed uterine perforation, severe haemorrhage, anaesthesia complications, incomplete evacuation requiring re-evacuations and infections complications requiring antibiotic treatmentTimepoint: 7-14 days after VA/MVA | — |
Countries
India
Contacts
Public ContactDr Rohini Sehgal
department of Ostetrics &Gynaecology All India Institute Of Medical sciences
Outcome results
None listed